Shenzhen, China

Guobin Ren

USPTO Granted Patents = 5 

Average Co-Inventor Count = 4.3

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
5 patents (USPTO):

Title: Guobin Ren: Innovator in Pharmaceutical Chemistry

Introduction

Guobin Ren is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 5 patents. His work focuses on the development of stable crystalline forms of various compounds, which are crucial for the pharmaceutical industry.

Latest Patents

Ren's latest patents include innovative formulations that enhance the stability and usability of pharmaceutical compounds. One of his notable patents is for a crystalline form A of 2,2-bis(4-fluorophenyl)-2-phenylacetamide. This crystalline form exhibits excellent light stability, high temperature stability, and high humidity stability, making it a valuable asset in drug formulation. Another significant patent is for the eutectic form A of Elagolix and pyrimethamine. This formulation demonstrates high purity and stability under various conditions, with minimal moisture absorption, which is essential for maintaining the integrity of pharmaceutical products.

Career Highlights

Throughout his career, Guobin Ren has worked with several companies, including Shenzhen Rentai Pharmatech Ltd and Shenzhen Jingtai Technology Co., Ltd. His experience in these organizations has allowed him to refine his skills in pharmaceutical development and innovation.

Collaborations

Ren has collaborated with notable colleagues in his field, including Dongxu Yi and Jiajun Huang. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Guobin Ren's contributions to pharmaceutical chemistry through his innovative patents highlight his expertise and commitment to improving drug formulations. His work continues to influence the industry, ensuring the development of stable and effective pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…